TRNX yields 2000000.00% · MRK yields 2.76%● Live data
📍 TRNX pulled ahead of the other in Year 1
Combined, TRNX + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TRNX + MRK for your $10,000?
Taronis Technologies, Inc., a technology-based company, focuses on addressing the constraints on natural resources primarily in the United States. The company offers MagneGas, a hydrogen-based synthetic fuel that is used as an alternative to acetylene and other natural gas derived fuels for metal cutting and other commercial uses. It also provides Plasma Arc Flow System for MagneGas production, or water decontamination and sterilization. In addition, the company sells and licenses its proprietary plasma arc technology for gasification and the processing of liquid waste. It distributes and sells MagneGas fuel, and other gases and welding supplies through retail locations. The company was formerly known as MagneGas Applied Technology Solutions, Inc. and changed its name to Taronis Technologies, Inc. in January 2019. Taronis Technologies, Inc. was founded in 2005 and is headquartered in Peoria, Arizona.
Full TRNX Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.